A Guilford company that provides artificial intelligence services to the pharmaceutical industry has inked a three-year collaboration with the consumer health division of German drugmaker GlaxoSmithKline.
The artificial intelligence and machine learning platform of InveniAI helps companies identify and develop new drugs for diseases with unmet needs.